Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 31, 2024 (Week 35) column labels (in same order that data fields appears in each record below): Reporting Area Carbapenemase-Producing Organisms (CPO), Total §; Current week Carbapenemase-Producing Organisms (CPO), Total §; Previous 52 weeks Max + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2024 + Carbapenemase-Producing Organisms (CPO), Total §; Cum YTD 2023 + tab delimited data: U.S. Residents, excluding U.S. Territories 47 NC 2,707 4,276 New England 5 NC 45 70 Connecticut - NC - - Maine 1 NC 8 33 Massachusetts - NC - - New Hampshire - NC 12 16 Rhode Island 4 NC 25 21 Vermont - NC - - Middle Atlantic - NC 101 371 New Jersey - NC - - New York (excluding New York City) - NC - - New York City - NC - 151 Pennsylvania - NC 101 220 East North Central 36 NC 1,310 1,649 Illinois - NC 11 501 Indiana - NC 205 260 Michigan - NC 109 212 Ohio 36 NC 960 649 Wisconsin - NC 25 27 West North Central - NC 92 183 Iowa - NC 36 65 Kansas - NC 52 62 Minnesota - NC - 48 Missouri - NC - - Nebraska - NC - - North Dakota - NC - 7 South Dakota - NC 4 1 South Atlantic 5 NC 371 569 Delaware - NC 15 11 District of Columbia - NC - - Florida N NC N N Georgia - NC - 212 Maryland - NC - - North Carolina - NC - 117 South Carolina - NC - - Virginia 5 NC 291 174 West Virginia - NC 65 55 East South Central - NC 57 138 Alabama N NC N N Kentucky - NC - - Mississippi - NC 57 138 Tennessee - NC - - West South Central - NC - 16 Arkansas - NC - - Louisiana - NC - 16 Oklahoma - NC - - Texas U NC U U Mountain 1 NC 715 678 Arizona - NC 689 543 Colorado - NC - - Idaho - NC - - Montana 1 NC 6 1 Nevada - NC 1 81 New Mexico - NC - - Utah - NC 19 52 Wyoming - NC - 1 Pacific - NC 16 602 Alaska - NC - - California - NC - 514 Hawaii - NC - 13 Oregon - NC 16 18 Washington - NC - 57 U.S. Territories - NC - 117 American Samoa - NC - - Commonwealth of Northern Mariana Islands - NC - - Guam - NC - - Puerto Rico - NC - 117 U.S. Virgin Islands - NC - - Non-U.S. Residents - NC 2 - Total 47 NC 2,709 4,393 U: Unavailable - The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases - The reporting jurisdiction did not submit any cases to CDC. N: Not reportable - The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable - This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published. NC: Not calculated - There is insufficient data available to support the calculation of this statistic. Cum: Cumulative year-to-date counts. * Case counts for reporting years 2023 and 2024 are provisional and subject to change. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/ § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.